Doug Brunk is a San Diego-based award-winning reporter who began covering health care in 1991. Before joining the company, he wrote for the health sciences division of Columbia University and was an associate editor at Contemporary Long Term Care magazine when it won a Jesse H. Neal Award. His work has been syndicated by the Los Angeles Times and he is the author of two books related to the University of Kentucky Wildcats men's basketball program. Doug has a master’s degree in magazine journalism from the S.I. Newhouse School of Public Communications at Syracuse University. Follow him on Twitter @dougbrunk.
News
Expert dispels myths about hair care in patients with skin of color
“You want to perform the scalp and hair exam with cultural humility,” Dr. Candrice R. Health said.
News
Topical or intralesional cidofovir an option for recalcitrant warts
Some studies have suggested that one in three children in primary school suffers from warts.
News
Treating nail psoriasis: Intralesional injections and biologics
When Dr. Armstrong performs intramatricial injections, she uses triamcinolone acetonide at 10 mg/mL.
News
Treating rosacea: Combination therapy, benzoyl peroxide, and the ‘STOP’ mnemonic
“We’ve been more comfortable with the idea of combination therapy for acne than we have been for rosacea,” Dr. Julie C. Harper said.
News
What does the future of psoriasis treatment look like?
“We have terrific drugs for psoriasis, but how can we do better?” Dr. Andrew Blauvelt asked.
News
How to manage isotretinoin’s bothersome mucocutaneous side effects
Often underappreciated is the potential for chronic dry eye and other ocular changes, Dr. John S. Barbieri said.
News
Expert discusses pros, cons of molecular tests for melanoma
Next generation sequencing allows for the generation of millions of sequencing reads that are aligned to a standard human genome, and likely...
News
How prevalent is pediatric melanoma?
As in adults, the stage correlates strongly with survival, and distant metastases carry a poor prognosis.
News
Optimal management of dysplastic nevi continues to evolve
“Misdiagnosis is more common for melanomas that have been assessed with punch and shave biopsies than with an excisional biopsy,” Dr. Benjamin...
News
Secukinumab shows benefit for hidradenitis suppurativa out to 52 weeks
“In my experience, optimizing treatment can take almost a year and I hope we will see longer controlled periods in future studies,” Dr. Alexa B....
News
More than 97K new cutaneous melanoma diagnoses expected in 2023
More than 1.3 million people in the United States live with cutaneous melanoma, and the overall 5-year survival is 93.7%.
News
Risk of infections low among kids receiving systemic meds for psoriasis, study finds
The analysis included 2,338 patients with psoriasis aged 17 years and younger who started new treatment with ustekinumab, etanercept, or...
News
Dermoscopy, other modalities for improving melanoma diagnoses reviewed
The learning curve for dermoscopy is steep, he added, and whether the technique should be considered a first-line tool or as a supplement to other...
News
Dermatopathologist reflects on the early history of melanoma
Melanoma was often regarded as a fungal infection in the early 1800s.
News
How should PRAME be used to evaluate melanocytic lesions?
One potential pitfall is that sun-damaged melanocytes may express PRAME.